| Product Code: ETC9508944 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname witnessed a decrease in connected drug delivery devices imports in 2024, with key exporting countries being Netherlands, Japan, Germany, USA, and Trinidad and Tobago. The market concentration, as measured by HHI, remained moderate, indicating a competitive landscape. The negative CAGR and growth rate suggest a challenging market environment, possibly impacted by various factors such as regulatory changes or economic conditions. It will be crucial for stakeholders to closely monitor trends and adapt strategies to navigate the evolving market dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Connected Drug Delivery Devices Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Connected Drug Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Connected Drug Delivery Devices Market - Industry Life Cycle |
3.4 Suriname Connected Drug Delivery Devices Market - Porter's Five Forces |
3.5 Suriname Connected Drug Delivery Devices Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Suriname Connected Drug Delivery Devices Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Suriname Connected Drug Delivery Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Suriname Connected Drug Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Suriname leading to higher demand for connected drug delivery devices |
4.2.2 Growing awareness about the benefits of connected drug delivery devices in improving medication adherence and management |
4.2.3 Technological advancements in connected drug delivery devices leading to more user-friendly and efficient products |
4.3 Market Restraints |
4.3.1 High cost associated with connected drug delivery devices limiting adoption rate, especially among low-income populations |
4.3.2 Limited healthcare infrastructure and access to advanced medical technologies in certain regions of Suriname |
5 Suriname Connected Drug Delivery Devices Market Trends |
6 Suriname Connected Drug Delivery Devices Market, By Types |
6.1 Suriname Connected Drug Delivery Devices Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Connected Drug Delivery Devices Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Suriname Connected Drug Delivery Devices Market Revenues & Volume, By Standalone Components & Software, 2021- 2031F |
6.1.4 Suriname Connected Drug Delivery Devices Market Revenues & Volume, By Integrated Devices, 2021- 2031F |
6.2 Suriname Connected Drug Delivery Devices Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Suriname Connected Drug Delivery Devices Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.3 Suriname Connected Drug Delivery Devices Market Revenues & Volume, By Inhalational, 2021- 2031F |
6.3 Suriname Connected Drug Delivery Devices Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Suriname Connected Drug Delivery Devices Market Revenues & Volume, By Asthma, 2021- 2031F |
6.3.3 Suriname Connected Drug Delivery Devices Market Revenues & Volume, By COPD, 2021- 2031F |
6.3.4 Suriname Connected Drug Delivery Devices Market Revenues & Volume, By Diabetes Management, 2021- 2031F |
6.3.5 Suriname Connected Drug Delivery Devices Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Connected Drug Delivery Devices Market Import-Export Trade Statistics |
7.1 Suriname Connected Drug Delivery Devices Market Export to Major Countries |
7.2 Suriname Connected Drug Delivery Devices Market Imports from Major Countries |
8 Suriname Connected Drug Delivery Devices Market Key Performance Indicators |
8.1 Patient engagement and satisfaction levels with connected drug delivery devices |
8.2 Adoption rate of connected drug delivery devices among healthcare providers in Suriname |
8.3 Number of partnerships and collaborations between technology companies and healthcare providers in the connected drug delivery devices market in Suriname |
9 Suriname Connected Drug Delivery Devices Market - Opportunity Assessment |
9.1 Suriname Connected Drug Delivery Devices Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Suriname Connected Drug Delivery Devices Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Suriname Connected Drug Delivery Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Suriname Connected Drug Delivery Devices Market - Competitive Landscape |
10.1 Suriname Connected Drug Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 Suriname Connected Drug Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |